Mike Thompson

Mike Thompson possesses over three decades of experience in the pharmaceutical and biotechnology sectors, with a significant tenure at FibroGen as Executive Director of Small Molecule Technical Development since January 2007. Prior roles include Associate Director at Cardinal Health (1999-2003), Section Head at Rhone-Poulenc Rorer (1991-1999), and Senior Research Scientist at Bristol-Myers Squibb (1983-1991). Mike Thompson holds a Postdoctorate in Organic Chemistry from Stanford University (1981-1982) and a PhD in Organic Chemistry from the University of Utah (1977-1981).